The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 04, 2014

Filed:

May. 26, 2009
Applicants:

James R. Baker, Jr., Ann Arbor, MI (US);

Paul E. Makidon, Webberville, MI (US);

Nicholas J. Mank, Ann Arbor, MI (US);

Anna U. Bielinska, Ypsilanti, MI (US);

Luz P. Blanco, Ann Arbor, MI (US);

Jessica Knowlton, Ypsilanti, MI (US);

Inventors:

James R. Baker, Jr., Ann Arbor, MI (US);

Paul E. Makidon, Webberville, MI (US);

Nicholas J. Mank, Ann Arbor, MI (US);

Anna U. Bielinska, Ypsilanti, MI (US);

Luz P. Blanco, Ann Arbor, MI (US);

Jessica Knowlton, Ypsilanti, MI (US);

Assignee:
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/116 (2006.01); A01N 63/00 (2006.01); A61K 45/00 (2006.01); A61K 39/00 (2006.01); A61K 39/38 (2006.01); A61K 39/02 (2006.01); A61K 39/08 (2006.01); A61K 39/07 (2006.01); A61K 9/107 (2006.01); A61K 39/29 (2006.01); A61K 39/39 (2006.01);
U.S. Cl.
CPC ...
A61K 39/292 (2013.01); A61K 2039/57 (2013.01); A61K 2039/543 (2013.01); A61K 39/08 (2013.01); C12N 2730/10134 (2013.01); A61K 9/1075 (2013.01); A61K 2039/55566 (2013.01); A61K 39/0291 (2013.01); A61K 39/39 (2013.01); A61K 39/07 (2013.01);
Abstract

The present invention provides methods and compositions for the stimulation of immune responses. Specifically, the present invention provides methods of inducing an immune response against one or a plurality of pathogens (e.g., vaccinia virus, H5N1 influenza virus,, Hepatitis B, and/or HIV, etc.) in a subject (e.g., a human subject) and compositions useful in such methods (e.g., immunogenic composition comprising nanoemulsion and one or a plurality of pathogens (e.g., inactivated by the nanoemulsion) and/or pathogen products and/or pathogen components). Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine (e.g., vaccination)) and research applications.


Find Patent Forward Citations

Loading…